Related Experiment Video
Updated: Apr 16, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Perioperatively acquired disorders of coagulation
Oliver Grottke1, Dietmar Fries, Bartolomeu Nascimento
1aDepartment of Anaesthesiology, RWTH Aachen University Hospital, Aachen, Germany bDepartment of Surgical and General Critical Care Medicine, Medical University Innsbruck, Innsbruck, Austria cDepartment of Surgery, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
Acquired coagulopathies, often linked to low fibrinogen, complicate surgeries and trauma. Reversing new oral anticoagulants remains challenging, with specific antidotes showing promise but not yet approved.
Area of Science:
- Anesthesiology
- Hematology
- Critical Care Medicine
Background:
- Acquired coagulopathies are common in perioperative settings, trauma, and postpartum hemorrhage.
- Low fibrinogen levels and impaired fibrin polymerization contribute to bleeding complications.
- Antithrombotic medications, including novel oral anticoagulants, pose challenges in managing surgical bleeding.
Purpose of the Study:
- To review acquired coagulopathies in diverse clinical scenarios.
- To discuss coagulation disturbances related to antithrombotic agents.
- To outline strategies for reversing antithrombotic effects during hemorrhage.
Main Methods:
- Literature review of recent studies on acquired coagulopathies.
- Analysis of fibrinogen levels and fibrin polymerization in bleeding patients.
- Evaluation of reversal strategies for antithrombotic medications.
Main Results:
- Fibrinogen deficits are prevalent after cardiopulmonary bypass, in trauma patients, and postpartum.
- Reversal of novel oral anticoagulants with nonspecific agents yields conflicting results.
- Specific antidotes for novel oral anticoagulants are under development with promising initial data.
Conclusions:
- Targeted hemostatic therapy aims to correct coagulopathies and minimize allogeneic transfusions.
- Guidelines exist for reversing warfarin and antiplatelet agents.
- Evidence-based recommendations for managing drug-induced coagulopathy from novel oral anticoagulants are limited.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation
Venous Thrombosis III: Interprofessional Care

